Annual Non Current Assets
$248.46 M
-$5.48 M-2.16%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual long term assets is $248.46 million, with the most recent change of -$5.48 million (-2.16%) on December 31, 2023.
- During the last 3 years, TBPH annual non current assets has risen by +$172.74 million (+228.14%).
- TBPH annual non current assets is now -2.16% below its all-time high of $253.94 million, reached on December 31, 2022.
Performance
TBPH Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$239.63 M
-$3.10 M-1.28%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly long term assets is $239.63 million, with the most recent change of -$3.10 million (-1.28%) on September 30, 2024.
- Over the past year, TBPH quarterly non current assets has dropped by -$12.28 million (-4.87%).
- TBPH quarterly non current assets is now -13.56% below its all-time high of $277.21 million, reached on March 31, 2023.
Performance
TBPH Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
TBPH Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.2% | -4.9% |
| 3 y3 years | +228.1% | +126.2% |
| 5 y5 years | +806.4% | +216.5% |
TBPH Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.2% | +98.8% | -13.6% | +91.8% |
| 5 y | 5-year | -2.2% | +253.2% | -13.6% | +289.9% |
| alltime | all time | -2.2% | +2144.2% | -13.6% | +2167.7% |
Theravance Biopharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $239.63 M(-1.3%) |
| Jun 2024 | - | $242.72 M(-1.7%) |
| Mar 2024 | - | $247.01 M(-0.6%) |
| Dec 2023 | $133.54 M(-62.2%) | $248.46 M(-1.4%) |
| Sep 2023 | - | $251.90 M(-1.1%) |
| Jun 2023 | - | $254.63 M(-8.1%) |
| Mar 2023 | - | $277.21 M(+9.2%) |
| Dec 2022 | $353.46 M(+41.5%) | $253.94 M(+0.9%) |
| Sep 2022 | - | $251.78 M(+22.2%) |
| Jun 2022 | - | $206.03 M(+36.7%) |
| Mar 2022 | - | $150.72 M(+20.6%) |
| Dec 2021 | $249.87 M(-36.5%) | $124.95 M(+17.9%) |
| Sep 2021 | - | $105.94 M(+10.3%) |
| Jun 2021 | - | $96.07 M(+17.1%) |
| Mar 2021 | - | $82.04 M(+8.3%) |
| Dec 2020 | $393.34 M(+16.2%) | $75.72 M(+23.2%) |
| Sep 2020 | - | $61.46 M(-6.8%) |
| Jun 2020 | - | $65.94 M(-7.4%) |
| Mar 2020 | - | $71.19 M(+1.2%) |
| Dec 2019 | $338.49 M | $70.34 M(-21.6%) |
| Sep 2019 | - | $89.69 M(+35.0%) |
| Jun 2019 | - | $66.41 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $64.03 M(+133.6%) |
| Dec 2018 | $532.82 M(+40.7%) | $27.41 M(-28.5%) |
| Sep 2018 | - | $38.36 M(+10.6%) |
| Jun 2018 | - | $34.67 M(+4.1%) |
| Mar 2018 | - | $33.29 M(-46.9%) |
| Dec 2017 | $378.75 M(-28.3%) | $62.65 M(-47.4%) |
| Sep 2017 | - | $119.03 M(-25.1%) |
| Jun 2017 | - | $159.00 M(-4.5%) |
| Mar 2017 | - | $166.53 M(+50.4%) |
| Dec 2016 | $528.50 M(+122.6%) | $110.75 M(+34.6%) |
| Sep 2016 | - | $82.25 M(+15.3%) |
| Jun 2016 | - | $71.36 M(+31.2%) |
| Mar 2016 | - | $54.37 M(-13.2%) |
| Dec 2015 | $237.47 M(-13.8%) | $62.64 M(+225.1%) |
| Sep 2015 | - | $19.27 M(-34.1%) |
| Jun 2015 | - | $29.25 M(-40.7%) |
| Mar 2015 | - | $49.34 M(-20.9%) |
| Dec 2014 | $275.37 M(+1852.1%) | $62.40 M(-16.8%) |
| Sep 2014 | - | $74.99 M(+56.7%) |
| Jun 2014 | - | $47.85 M(+352.9%) |
| Mar 2014 | - | $10.57 M(-4.6%) |
| Dec 2013 | $14.11 M | $11.07 M |
FAQ
- What is Theravance Biopharma annual long term assets?
- What is the all time high annual non current assets for Theravance Biopharma?
- What is Theravance Biopharma annual non current assets year-on-year change?
- What is Theravance Biopharma quarterly long term assets?
- What is the all time high quarterly non current assets for Theravance Biopharma?
- What is Theravance Biopharma quarterly non current assets year-on-year change?
What is Theravance Biopharma annual long term assets?
The current annual non current assets of TBPH is $248.46 M
What is the all time high annual non current assets for Theravance Biopharma?
Theravance Biopharma all-time high annual long term assets is $253.94 M
What is Theravance Biopharma annual non current assets year-on-year change?
Over the past year, TBPH annual long term assets has changed by -$5.48 M (-2.16%)
What is Theravance Biopharma quarterly long term assets?
The current quarterly non current assets of TBPH is $239.63 M
What is the all time high quarterly non current assets for Theravance Biopharma?
Theravance Biopharma all-time high quarterly long term assets is $277.21 M
What is Theravance Biopharma quarterly non current assets year-on-year change?
Over the past year, TBPH quarterly long term assets has changed by -$12.28 M (-4.87%)